Background/Aim: Loss of differentiation of breast cancer cells in association with a down-
regulated class I human leukocyte antigen (HLA) expression can lead to proliferation …

Background Human leukocyte antigen (HLA)-class I molecules on tumor cells have been
regarded as crucial sites where cytotoxic T lymphocytes (CTL) can recognize tumor-specific …

Background The value of human leukocyte antigen (HLA; also known as major
histocompatibility complex) class I expression for the prediction of breast cancer survival …

The underlying basis for cancer immune evasion is important for effective immunotherapy
and prognosis in breast cancers. Human leucocyte antigens (HLA)-I comprising three …

There is evidence indicating that changes in the expression of HLA‐ABC antigens can
modulate the biological behavior and metastatic potential of certain neoplasms. We studied …

Investigation is lacking regarding the clinical impact of human leukocyte antigen (HLA) class
I downregulation in breast cancer and results are inconsistent. In this study, we investigated …

Downregulation of human leukocyte antigen (HLA) class I is one mechanism of escaping
anti-tumor immunity by tumor cells. This study was conducted to compare HLA class I …

Deficient expression of HLA class-I molecules observed in many cancers is suggested to
influence both disease progression and potential efficacy of T cell-mediated immune …

This study is aimed at investigating whether or not human leukocyte antigen-G (HLA-G)
expression is associated with breast cancer molecular subtypes. HLA-G expression was …

Background Human leukocyte antigen class I (HLA-I) molecules play important roles in
regulating immune responses. Loss or reduction of HLA-I expression has been shown to be …